Cody is a principal is ZS’s New York office, focused on early-stage commercial development, business development, M&A, and franchise growth strategy. He leads ZS’s Center of Excellence (COE) and is a member of the COIVID-19 vaccine COE. He serves as a subject matter expert for manufacturers involved in developing assets specific to COVID-19.

He has over 11 years of experience in healthcare and life sciences consulting across a range of strategy issues, including early-stage opportunity assessment, business development and licensing, and asset valuation. His work in infectious disease spans vaccines and anti-infectives, ranging from development stage biotechs to large cap pharma.

 

He has published extensively on COVID-19 vaccines and treatment since the beginning of the pandemic, in addition to supporting vaccine and treatment manufacturers on key decisions throughout the pandemic. Cody has also appeared in several media outlets to discuss COVID-19 vaccine development.

Cody originally joined ZS in 2006 and later re-joined in 2016.  Prior to re-joining, he was a consultant with both L.E.K. Consulting and the Frankel Group (now part of Huron Consulting).

He holds an MBA from the Ross School of Business at the University of Michigan and a B.S. from Rensselaer Polytechnic Institute.